Loading…

Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study

Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[18F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the first yea...

Full description

Saved in:
Bibliographic Details
Published in:Movement disorders 2006-07, Vol.21 (7), p.958-963
Main Authors: Brück, Anna, Aalto, Sargo, Nurmi, Elina, Vahlberg, Tero, Bergman, Jörgen, Rinne, Juha O.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5215-4b33dfb630f8b150353fa818382d6259ffac20f57a7efcf0e60fc94fcdd2b10e3
cites cdi_FETCH-LOGICAL-c5215-4b33dfb630f8b150353fa818382d6259ffac20f57a7efcf0e60fc94fcdd2b10e3
container_end_page 963
container_issue 7
container_start_page 958
container_title Movement disorders
container_volume 21
creator Brück, Anna
Aalto, Sargo
Nurmi, Elina
Vahlberg, Tero
Bergman, Jörgen
Rinne, Juha O.
description Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[18F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the first years of early PD. Twenty‐four healthy controls underwent one F‐dopa PET scan. The regional differences in the striatal and extrastriatal regions were analyzed with statistical parametric mapping and automated region of interest analyses. Our study shows that the F‐dopa uptake in unmedicated early PD is most severely decreased in the dorsal part of caudal putamen but significant decrease can be seen throughout the striatum compared with controls. During the first years of PD, there is a progressive regional decline in striatal F‐dopa uptake, the dorsal part of caudal putamen being still the most severely affected region. The absolute decline is equal between the striatal subregions. This suggests that the decline of dopamine function starts from the dorsocaudal putamen, but once started, the rate of progression is equal between the subregions of the striatum. In contrast to the striatal decline, the increased cortical F‐dopa uptake prevails at least during the first years of PD. © 2006 Movement Disorder Society
doi_str_mv 10.1002/mds.20855
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68784874</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808711233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5215-4b33dfb630f8b150353fa818382d6259ffac20f57a7efcf0e60fc94fcdd2b10e3</originalsourceid><addsrcrecordid>eNqF0U1v1DAQBmALgehSOPAHkC98HdzO2HHicqsKu4CWD7GgIiFkOYmN3HrjxU605N-Tsgs9AaeZwzMz0ryE3Ec4QgB-vG7zEQcl5Q0yQymQKS6rm2QGSkkmUMkDcifnCwBEieVtcoCllCALOSN-1SdvehNoHupkv_nYTX3JvqCaf3VhiCmyJWvjxtBh05tLS31HrUlhpO9NuvRdjt3jTFufrcn2GT2l_TaycRLUxRDilg0bmvuhHe-SW86EbO_t6yH5NH_x8ewlW75bvDo7XbJGcpSsqIVoXV0KcKpGCUIKZxQqoXhbcnninGk4OFmZyrrGgS3BNSeFa9qW1whWHJJHu72bFL8PNvd67XNjQzCdjUPWpapUoariv5BP36oKuIJP_glRgaoQuRATfbqjTYo5J-v0Jvm1SaNG0FdZ6Skr_SuryT7Yrx3qtW2v5T6cCTzcA5MbE1wyXePztVMAEgVM7njntj7Y8e8X9Zvnq9-n2W7C597--DMxBarLSlRSn79d6MV8_nn1-sO5XomfmY25nA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1808711233</pqid></control><display><type>article</type><title>Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study</title><source>Wiley</source><creator>Brück, Anna ; Aalto, Sargo ; Nurmi, Elina ; Vahlberg, Tero ; Bergman, Jörgen ; Rinne, Juha O.</creator><creatorcontrib>Brück, Anna ; Aalto, Sargo ; Nurmi, Elina ; Vahlberg, Tero ; Bergman, Jörgen ; Rinne, Juha O.</creatorcontrib><description>Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[18F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the first years of early PD. Twenty‐four healthy controls underwent one F‐dopa PET scan. The regional differences in the striatal and extrastriatal regions were analyzed with statistical parametric mapping and automated region of interest analyses. Our study shows that the F‐dopa uptake in unmedicated early PD is most severely decreased in the dorsal part of caudal putamen but significant decrease can be seen throughout the striatum compared with controls. During the first years of PD, there is a progressive regional decline in striatal F‐dopa uptake, the dorsal part of caudal putamen being still the most severely affected region. The absolute decline is equal between the striatal subregions. This suggests that the decline of dopamine function starts from the dorsocaudal putamen, but once started, the rate of progression is equal between the subregions of the striatum. In contrast to the striatal decline, the increased cortical F‐dopa uptake prevails at least during the first years of PD. © 2006 Movement Disorder Society</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.20855</identifier><identifier>PMID: 16550545</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>[18F]fluorodopa ; Aged ; Biological and medical sciences ; Corpus Striatum - diagnostic imaging ; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases ; Dihydroxyphenylalanine - analogs &amp; derivatives ; Dihydroxyphenylalanine - pharmacokinetics ; Disease Progression ; Dominance, Cerebral - physiology ; Female ; Fluorine Radioisotopes - pharmacokinetics ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Middle Aged ; Nervous system (semeiology, syndromes) ; Neurology ; Parkinson Disease - diagnostic imaging ; Parkinson's disease ; Positron-Emission Tomography ; progression ; Putamen - diagnostic imaging ; Reference Values</subject><ispartof>Movement disorders, 2006-07, Vol.21 (7), p.958-963</ispartof><rights>Copyright © 2006 Movement Disorder Society</rights><rights>2006 INIST-CNRS</rights><rights>(c) 2006 Movement Disorder Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5215-4b33dfb630f8b150353fa818382d6259ffac20f57a7efcf0e60fc94fcdd2b10e3</citedby><cites>FETCH-LOGICAL-c5215-4b33dfb630f8b150353fa818382d6259ffac20f57a7efcf0e60fc94fcdd2b10e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18005130$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16550545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brück, Anna</creatorcontrib><creatorcontrib>Aalto, Sargo</creatorcontrib><creatorcontrib>Nurmi, Elina</creatorcontrib><creatorcontrib>Vahlberg, Tero</creatorcontrib><creatorcontrib>Bergman, Jörgen</creatorcontrib><creatorcontrib>Rinne, Juha O.</creatorcontrib><title>Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study</title><title>Movement disorders</title><addtitle>Mov. Disord</addtitle><description>Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[18F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the first years of early PD. Twenty‐four healthy controls underwent one F‐dopa PET scan. The regional differences in the striatal and extrastriatal regions were analyzed with statistical parametric mapping and automated region of interest analyses. Our study shows that the F‐dopa uptake in unmedicated early PD is most severely decreased in the dorsal part of caudal putamen but significant decrease can be seen throughout the striatum compared with controls. During the first years of PD, there is a progressive regional decline in striatal F‐dopa uptake, the dorsal part of caudal putamen being still the most severely affected region. The absolute decline is equal between the striatal subregions. This suggests that the decline of dopamine function starts from the dorsocaudal putamen, but once started, the rate of progression is equal between the subregions of the striatum. In contrast to the striatal decline, the increased cortical F‐dopa uptake prevails at least during the first years of PD. © 2006 Movement Disorder Society</description><subject>[18F]fluorodopa</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Corpus Striatum - diagnostic imaging</subject><subject>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</subject><subject>Dihydroxyphenylalanine - analogs &amp; derivatives</subject><subject>Dihydroxyphenylalanine - pharmacokinetics</subject><subject>Disease Progression</subject><subject>Dominance, Cerebral - physiology</subject><subject>Female</subject><subject>Fluorine Radioisotopes - pharmacokinetics</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Parkinson Disease - diagnostic imaging</subject><subject>Parkinson's disease</subject><subject>Positron-Emission Tomography</subject><subject>progression</subject><subject>Putamen - diagnostic imaging</subject><subject>Reference Values</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqF0U1v1DAQBmALgehSOPAHkC98HdzO2HHicqsKu4CWD7GgIiFkOYmN3HrjxU605N-Tsgs9AaeZwzMz0ryE3Ec4QgB-vG7zEQcl5Q0yQymQKS6rm2QGSkkmUMkDcifnCwBEieVtcoCllCALOSN-1SdvehNoHupkv_nYTX3JvqCaf3VhiCmyJWvjxtBh05tLS31HrUlhpO9NuvRdjt3jTFufrcn2GT2l_TaycRLUxRDilg0bmvuhHe-SW86EbO_t6yH5NH_x8ewlW75bvDo7XbJGcpSsqIVoXV0KcKpGCUIKZxQqoXhbcnninGk4OFmZyrrGgS3BNSeFa9qW1whWHJJHu72bFL8PNvd67XNjQzCdjUPWpapUoariv5BP36oKuIJP_glRgaoQuRATfbqjTYo5J-v0Jvm1SaNG0FdZ6Skr_SuryT7Yrx3qtW2v5T6cCTzcA5MbE1wyXePztVMAEgVM7njntj7Y8e8X9Zvnq9-n2W7C597--DMxBarLSlRSn79d6MV8_nn1-sO5XomfmY25nA</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Brück, Anna</creator><creator>Aalto, Sargo</creator><creator>Nurmi, Elina</creator><creator>Vahlberg, Tero</creator><creator>Bergman, Jörgen</creator><creator>Rinne, Juha O.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>8BM</scope></search><sort><creationdate>200607</creationdate><title>Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study</title><author>Brück, Anna ; Aalto, Sargo ; Nurmi, Elina ; Vahlberg, Tero ; Bergman, Jörgen ; Rinne, Juha O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5215-4b33dfb630f8b150353fa818382d6259ffac20f57a7efcf0e60fc94fcdd2b10e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>[18F]fluorodopa</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Corpus Striatum - diagnostic imaging</topic><topic>Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases</topic><topic>Dihydroxyphenylalanine - analogs &amp; derivatives</topic><topic>Dihydroxyphenylalanine - pharmacokinetics</topic><topic>Disease Progression</topic><topic>Dominance, Cerebral - physiology</topic><topic>Female</topic><topic>Fluorine Radioisotopes - pharmacokinetics</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Parkinson Disease - diagnostic imaging</topic><topic>Parkinson's disease</topic><topic>Positron-Emission Tomography</topic><topic>progression</topic><topic>Putamen - diagnostic imaging</topic><topic>Reference Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brück, Anna</creatorcontrib><creatorcontrib>Aalto, Sargo</creatorcontrib><creatorcontrib>Nurmi, Elina</creatorcontrib><creatorcontrib>Vahlberg, Tero</creatorcontrib><creatorcontrib>Bergman, Jörgen</creatorcontrib><creatorcontrib>Rinne, Juha O.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>ComDisDome</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brück, Anna</au><au>Aalto, Sargo</au><au>Nurmi, Elina</au><au>Vahlberg, Tero</au><au>Bergman, Jörgen</au><au>Rinne, Juha O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov. Disord</addtitle><date>2006-07</date><risdate>2006</risdate><volume>21</volume><issue>7</issue><spage>958</spage><epage>963</epage><pages>958-963</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>Thirty‐one drug‐naive patients with Parkinson's disease (PD) underwent 6‐[18F]fluoro‐L‐dopa (F‐dopa) positron emission tomography (PET) scan at the time of the diagnosis (baseline) and 2 years later in order to investigate F‐dopa uptake in striatal and extrastriatal regions during the first years of early PD. Twenty‐four healthy controls underwent one F‐dopa PET scan. The regional differences in the striatal and extrastriatal regions were analyzed with statistical parametric mapping and automated region of interest analyses. Our study shows that the F‐dopa uptake in unmedicated early PD is most severely decreased in the dorsal part of caudal putamen but significant decrease can be seen throughout the striatum compared with controls. During the first years of PD, there is a progressive regional decline in striatal F‐dopa uptake, the dorsal part of caudal putamen being still the most severely affected region. The absolute decline is equal between the striatal subregions. This suggests that the decline of dopamine function starts from the dorsocaudal putamen, but once started, the rate of progression is equal between the subregions of the striatum. In contrast to the striatal decline, the increased cortical F‐dopa uptake prevails at least during the first years of PD. © 2006 Movement Disorder Society</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16550545</pmid><doi>10.1002/mds.20855</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-3185
ispartof Movement disorders, 2006-07, Vol.21 (7), p.958-963
issn 0885-3185
1531-8257
language eng
recordid cdi_proquest_miscellaneous_68784874
source Wiley
subjects [18F]fluorodopa
Aged
Biological and medical sciences
Corpus Striatum - diagnostic imaging
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Dihydroxyphenylalanine - analogs & derivatives
Dihydroxyphenylalanine - pharmacokinetics
Disease Progression
Dominance, Cerebral - physiology
Female
Fluorine Radioisotopes - pharmacokinetics
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Magnetic Resonance Imaging
Male
Medical sciences
Middle Aged
Nervous system (semeiology, syndromes)
Neurology
Parkinson Disease - diagnostic imaging
Parkinson's disease
Positron-Emission Tomography
progression
Putamen - diagnostic imaging
Reference Values
title Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: A two-year follow-up study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T18%3A17%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Striatal%20subregional%206-%5B18F%5Dfluoro-L-dopa%20uptake%20in%20early%20Parkinson's%20disease:%20A%20two-year%20follow-up%20study&rft.jtitle=Movement%20disorders&rft.au=Br%C3%BCck,%20Anna&rft.date=2006-07&rft.volume=21&rft.issue=7&rft.spage=958&rft.epage=963&rft.pages=958-963&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.20855&rft_dat=%3Cproquest_cross%3E1808711233%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5215-4b33dfb630f8b150353fa818382d6259ffac20f57a7efcf0e60fc94fcdd2b10e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1808711233&rft_id=info:pmid/16550545&rfr_iscdi=true